⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4806141 | 0.82 | — | — | |
| SCHEMBL6335738 | 0.78 | — | — | |
| SCHEMBL2752470 | 0.74 | — | — | |
| SCHEMBL15018278 | 0.74 | — | — | |
| SCHEMBL19489335 | 0.74 | — | — | |
| SCHEMBL2749864 | 0.70 | — | — | |
| SCHEMBL5556956 | 0.69 | — | — | |
| SCHEMBL6302424 | 0.68 | — | — | |
| SCHEMBL8005753 | 0.66 | KIF11 (0.36) | — | |
| SCHEMBL4801625 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8486954-B2 | Heterobicyclic carboxamides as inhibitors for kinases | NOVARTIS AG (CH) | 2013-07-16 | — | — | US | disclosed |
| US-20130005751-A1 | HETEROBICYCLIC CARBOXAMIDES AS INHIBITORS FOR KINASES | NOVARTIS AG (CH) | 2013-01-03 | — | — | US | disclosed |
| CN-101443318-A | Heterobicyclic carboxamides as inhibitors for kinases | NOVARTIS AG (CH) | 2009-05-27 | — | — | CN | disclosed |
| WO-1997005117-A1 | SUBSTITUTED 1-PHENYLURACIL DERIVATIVES, THEIR PREPARATION AND THEIR USE AS HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-02-13 | — | — | WO | disclosed |